Kalehua Capital Management LLC
Follow13F filer, CIK 2106181, DALLAS, TX
Kalehua Capital Management LLC reported $173,960,282 across 26 holdings for the quarter ended 2026-06-30, in a 13F-HR/A filed 2026-08-19. Its ten largest share positions make up 70.75% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR/A 0002106181-26-000008
A NEW HOLDINGS amendment repeated most of the original and was read as a restatement (H3).
- Period
- 2026-06-30
- Reported value
- $174M
- Holdings
- 26
- Top 10 weight
- 70.75%
- New
- 8
- Sold out
- 7
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| KPTInew | +685,644 | $6.7M |
| IFRXnew | +2,897,769 | $6.49M |
| CYCNnew | +1,651,350 | $5.6M |
| KRROadded | +295,664 | $3.9M |
| ANLnew | +226,415 | $2.6M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| QUREreduced | -211,702 | -$9.75M |
| RLAYexited | -901,457 | -$8.97M |
| ORKAexited | -118,524 | -$5.81M |
| PEPGexited | -1,000,000 | -$1.77M |
| TNYAexited | -2,000,000 | -$1.38M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2026
Share positions as resolved from 13F-HR/A 0002106181-26-000008, largest first. % of portfolio is the value over $173,960,282, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| BOXXEA SERIES TRUST | 226,188 | $26.5M | 15.22% | +7,910 | Timeline | ||
| MANEVERADERMICS INC | 145,695 | $17.9M | 10.3% | 0 | Timeline | ||
| XFORX4 PHARMACEUTICALS INC | 3,722,840 | $17.4M | 9.99% | 0 | Timeline | ||
| CMPSCOMPASS PATHWAYS PLC | 819,692 | $11.6M | 6.67% | 0 | Timeline | ||
| SRZNSURROZEN INC | 385,178 | $10M | 5.75% | 0 | Timeline | ||
| ACRSACLARIS THERAPEUTICS INC | 1,832,365 | $9.69M | 5.57% | 0 | Timeline | ||
| SIONSIONNA THERAPEUTICS INC | 197,072 | $8.67M | 4.98% | 0 | Timeline | ||
| IKTINHIBIKASE THERAPEUTICS INC | 3,821,890 | $7.76M | 4.46% | 0 | Timeline | ||
| PHVSPHARVARIS N V | 198,772 | $6.87M | 3.95% | 0 | Timeline | ||
| KPTIKARYOPHARM THERAPEUTICS INC | 685,644 | $6.7M | 3.85% | new | Timeline | ||
| SEPNSEPTERNA INC | 194,544 | $6.52M | 3.75% | 0 | Timeline | ||
| IFRXINFLARX NV | 2,897,769 | $6.49M | 3.73% | new | Timeline | ||
| CYCNCYCLERION THERAPEUTICS INC | 1,651,350 | $5.6M | 3.22% | new | Timeline | ||
| KRROKORRO BIO INC | 405,040 | $5.34M | 3.07% | +295,664 | Timeline | ||
| QUREUNIQURE NV | 79,407 | $3.66M | 2.1% | -211,702 | Timeline | ||
| LONALEONABIO INC | 393,701 | $3.62M | 2.08% | 0 | Timeline | ||
| DMRADAMORA THERAPEUTICS INC | 139,000 | $3.62M | 2.08% | 0 | Timeline | ||
| MLTXMOONLAKE IMMUNOTHERAPEUTICS | 175,734 | $3.42M | 1.97% | 0 | Timeline | ||
| ANLADLAI NORTYE GROUP LTD | 226,415 | $2.6M | 1.5% | new | Timeline | ||
| TYRATYRA BIOSCIENCES INC | 74,465 | $2.38M | 1.37% | 0 | Timeline | ||
| NVCTNUVECTIS PHARMA INC | 100,000 | $1.84M | 1.06% | new | Timeline | ||
| GOSSGOSSAMER BIO INC | 11,149,363 | $1.84M | 1.05% | +913,070 | Timeline | ||
| MISTMILESTONE PHARMACEUTICALS IN | 1,269,237 | $1.7M | 0.98% | new | Timeline | ||
| ATYRATYR PHARMA INC | 1,788,167 | $1.07M | 0.61% | new | Timeline | ||
| TILINSTIL BIO INC | 99,600 | $766K | 0.44% | -83,430 | Timeline | ||
| TCRXTSCAN THERAPEUTICS INC | 454,876 | $446K | 0.26% | new | Timeline |
Sold out in Q2 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| RLAYRELAY THERAPEUTICS INC | 901,457 | $8.97M | shares |
| ORKAORUKA THERAPEUTICS INC | 118,524 | $5.81M | shares |
| PEPGPEPGEN INC | 1,000,000 | $1.77M | shares |
| TNYATENAYA THERAPEUTICS INC | 2,000,000 | $1.38M | shares |
| KLRSKALARIS THERAPEUTICS INC | 135,585 | $782K | shares |
| DMACDIAMEDICA THERAPEUTICS INC | 62,488 | $423K | shares |
| LOOPLOOP INDS INC | 347,539 | $361K | shares |
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0002106181-26-000007 | superseded | 2026-08-14 | acceptance time not in the bulk data set | ||
| 13F-HR/A 0002106181-26-000008 | base | new holdings | 2026-08-19 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR/A 0002106181-26-000008 | Quarter ended 2026-06-30 | 2026-08-19 | acceptance time not in the bulk data set | |
| 13F-HR 0002106181-26-000007 | Quarter ended 2026-06-30 | 2026-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0002106181-26-000005 | Quarter ended 2026-03-31 | 2026-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0002106181-26-000004 | Quarter ended 2026-03-31 | 2026-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0002106181-26-000003 | Quarter ended 2025-12-31 | 2026-02-13 | acceptance time not in the bulk data set |